The association between miR-632 and major adverse cardiovascular and cerebrovascular events in patients with end-stage renal disease undergoing long-term hemodialysis

Jun Long

doi:10.1186/s12882-025-04654-7

November 27, 2025BMC NephrologyOpen Access

The association between miR-632 and major adverse cardiovascular and cerebrovascular events in patients with end-stage renal disease undergoing long-term hemodialysis

View Full Paper

Ask AI

Bookmark

Share

Key Points

miR-632 is associated with major adverse cardiovascular events in patients with end-stage renal disease,
indicating its potential as a risk factor for complications during treatment.
Assessment using clinical data from patients undergoing long-term hemodialysis reveals important insights.
Further evaluation is necessary to determine the role of miR-632 in clinical practice.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Observational analysis shows miR-632 as a risk factor for adverse cardiovascular events in end-stage renal disease patients, suggesting its role in patient outcomes.

Abstract

miR-632 is a risk factor for MACCE in ESRD patients undergoing long-term hemodialysis.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Jun Long (2025) studied this question.

synapsesocial.com/papers/692e3d626c9b3ab28c186d10 https://doi.org/10.1186/s12882-025-04654-7

View Full Paper

Ask AI

Bookmark

Share

The association between miR-632 and major adverse cardiovascular and cerebrovascular events in patients with end-stage renal disease undergoing long-term hemodialysis

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

The association between miR-632 and major adverse cardiovascular and cerebrovascular events in patients with end-stage renal disease undergoing long-term hemodialysis

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading